EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
CHEBI:232874 - nisoxetine hydrochloride
| Formula | C17H21NO2.HCl |
| Net Charge | 0 |
| Average Mass | 307.821 |
| Monoisotopic Mass | 307.13391 |
| SMILES | CNCCC(Oc1ccccc1OC)c1ccccc1.Cl |
| InChI | InChI=1S/C17H21NO2.ClH/c1-18-13-12-15(14-8-4-3-5-9-14)20-17-11-7-6-10-16(17)19-2;/h3-11,15,18H,12-13H2,1-2H3;1H |
| InChIKey | LCEURBZEQJZUPV-UHFFFAOYSA-N |
| Roles Classification |
|---|
| Biological Role: | adrenergic uptake inhibitor Adrenergic uptake inhibitors are drugs that block the transport of adrenergic transmitters into axon terminals or into storage vesicles within terminals. The tricyclic antidepressants and amphetamines are among the therapeutically important drugs that may act via inhibition of adrenergic transport. Many of these drugs also block transport of serotonin. |
| Application: | adrenergic uptake inhibitor Adrenergic uptake inhibitors are drugs that block the transport of adrenergic transmitters into axon terminals or into storage vesicles within terminals. The tricyclic antidepressants and amphetamines are among the therapeutically important drugs that may act via inhibition of adrenergic transport. Many of these drugs also block transport of serotonin. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| nisoxetine hydrochloride (CHEBI:232874) has part nisoxetine (CHEBI:73410) |
| nisoxetine hydrochloride (CHEBI:232874) has role adrenergic uptake inhibitor (CHEBI:35640) |
| nisoxetine hydrochloride (CHEBI:232874) is a organic molecular entity (CHEBI:50860) |
| IUPAC Name |
|---|
| 3-(2-methoxyphenoxy)-N-methyl-3-phenylpropan-1-amine;hydrochloride |
| Registry Numbers | Sources |
|---|---|
| CAS:57754-86-6 | SUBMITTER |
| Citations |
|---|